InvestorsHub Logo
Followers 2
Posts 34
Boards Moderated 1
Alias Born 07/14/2015

Re: None

Wednesday, 02/15/2017 5:40:50 PM

Wednesday, February 15, 2017 5:40:50 PM

Post# of 295
New updates on NKTR-181 - the novel opioid for chronic pain, presented by Stephen Doberstein , Senior Vice President and Chief Scientific Officer from Nektar Therapeutics. More information on the talk at the 17th Annual Pain Therapeutics summit in London are available at http://www.pain-therapeutics.co.uk/ihub
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News